Crossmark

Prevalence of polypharmacy and associated factors among patients living with HIV infection in Spain: The POINT study

Crossref DOI link: https://doi.org/10.1016/j.eimc.2020.09.020

Published Print: 2022-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Morillo-Verdugo, Ramón

Sánchez-Rubio-Ferrández, Javier

Gimeno-Gracia, Mercedes

Robustillo-Cortés, María de las Aguas

Almeida-González, Carmen V.
Funding

Funding for this research was provided by:

Merck Sharp and Dohme (74.810 €, IISP 54910)

Sociedad Española de Farmacia Hospitalaria
License Information

Text and Data Mining valid from 2022-01-01
More Information

This article is maintained by: Elsevier

Article Title: Prevalence of polypharmacy and associated factors among patients living with HIV infection in Spain: The POINT study

Journal Title: Enfermedades Infecciosas y Microbiología Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.eimc.2020.09.020

Content Type: article

Copyright: © 2020 Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. All rights reserved.